Buzz Stocks: Smith & Wesson Holding Corp, Marinus Pharmaceuticals Inc, and LinkedIn Corp

Today's stocks to watch in the news include Smith & Wesson Holding Corp (NASDAQ:SWHC), Marinus Pharmaceuticals Inc (NASDAQ:MRNS), and LinkedIn Corp (NYSE:LNKD)

by Josh Selway

Published on Jun 13, 2016 at 9:28 AM
Updated on Jun 14, 2016 at 8:03 AM

Global "Brexit" woes and sinking crude oil are weighing on U.S. stock futures this morning. Among the equities in focus today are gun stock Smith & Wesson Holding Corp (NASDAQ:SWHC), biotech Marinus Pharmaceuticals Inc (NASDAQ:MRNS), and professional networking expert LinkedIn Corp (NYSE:LNKD)

  • SWHC is set to pop 7.5% at the open, as gun stocks surge pre-market following Sunday's mass shooting in Orlando. After a strong start to the year, the gun stock has cooled since March, though the 200-day moving average has contained its most recent pullback, with the shares closing Friday at $21.41. Elsewhere, Smith & Wesson Holding Corp call options have been popular, with the stock's 10-day call/put volume ratio coming in at 4.48 across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Looking ahead, the arms manufacturer will report earnings Thursday night.
  • MRNS is selling off in pre-market trading, down 62.5%, after the company's epilepsy treatment failed to meet its goals in a late-stage study. Marinus Pharmaceuticals Inc said it would discontinue the study as a result. Looking back, the stock was trading above $20 per share less than a year ago, but closed Friday at $5.34, and is now poised to open at a record low. This drastic move lower could spell a round of analyst downgrades, since all four brokerage firms that cover MRNS recommend buying it. 
  • LNKD was last seen 48% higher in electronic trading, thanks to news Microsoft Corporation (NASDAQ:MSFT) will buy the company for $196 per share in an all-cash deal valued above $26 billion. LinkedIn Corp was down 41.8% year-to-date as of Friday's close at $131.08, mostly due to its post-earnings bear gap from February. Today's pending price action comes as terrible news to recent short sellers. Specifically, short interest increased by over 12% over the past two reporting periods. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.